Graham Boulnois, a life sciences businessman and academic, has been appointed chairman of the Medicines Technologies Catapult.
Boulnois is the founder and managing director of health care consultancy B-V Life Sciences and has previously held chairman or non-executive director roles at AstraZeneca, Aventis Pharma and the University of Leicester.
In a statement published on 18 January, Boulnois said he was delighted to have been appointed to the role, adding that he wanted the catapult to be recognised “as the leading place to develop these new technologies”.
This article is only available to Research Professional News subscribers or Pivot-RP users.
If you are a Research Professional News subscriber you can log in and view the article via this link
Pivot-RP users can log in and view the article via this link.